CCDM Exam Dumps : Certified Clinical Data Manager

Theprimary reasondata managers review data before a monitor’s review is toidentify and flag discrepancies or inconsistenciesso that site monitors can focus their efforts more efficiently during on-site or remote source data verification (SDV).

According to theGood Clinical Data Management Practices (GCDMP, Chapter on Data Validation and Cleaning), proactive data review by data management staff ensures data completeness and accuracy by identifying missing, inconsistent, or out-of-range values. This pre-review helps streamline the monitoring process, reduces the volume of open queries, and enhances data quality.

Option A is true but not the main reason for pre-monitor review. Option C highlights a capability rather than a rationale. Option D is partially correct, but the GCDMP emphasizesprocess purpose, not prescriptive order. Thus,option Bcorrectly captures the practical and process-oriented reason for early data review—to ensure data are ready and accurate for the monitor’s review phase.

Reference (CCDM-Verified Sources):

SCDM GCDMP, Chapter: Data Validation and Cleaning, Section 5.3 – Data Review Timing and Purpose

ICH E6(R2) GCP, Section 5.18 – Monitoring and Data Verification Requirements

In aSQL (Structured Query Language)database, theSELECTstatement specifies which columns to display from a table. In this query, only three columns —Pt_ID,MRN, andSSN— are being selected from thepatienttable.

This means the resulting dataset will contain:

The same number ofrows (records)as the original table (assuming noWHEREfilter), and

Fewer columnsthan the full table.

In database terminology:

“Wider” refers to more columns (fields).

“Narrower” refers to fewer columns (fields).

Since this query retrieves only 3 columns (out of potentially many in the original table), the result set isnarrower than the patient table, makingoption Dcorrect.

Reference (CCDM-Verified Sources):

SCDM GCDMP, Chapter: Database Design and Build, Section 5.1 – Relational Databases and Query Logic

ICH E6(R2) GCP, Section 5.5.3 – Data Retrieval and Integrity Principles

FDA Guidance for Industry: Computerized Systems Used in Clinical Investigations, Section 6.4 – Database Query Controls

The most significant difference in theData Manager’s rolewhen using anElectronic Data Capture (EDC)system is thatdata updates are implemented directly by site personnel(Option A).

According to theGCDMP (Chapter: Electronic Data Capture Systems), EDC technology shifts responsibility for data entry and correction from the sponsor or CRO to the investigator site, enabling real-time data entry and validation. This eliminates the need for double entry or remote data transcription, allowing Data Managers to focus onsystem validation, query management, and data quality oversightrather than physical data handling.

However, the EDC system still requires full validation (contrary to Option B). Metrics generation (Option C) and CRF tracking (Option D) are important but not unique to EDC-based workflows.

Thus, the correct answer isOption A – Data updates are implemented by the sites, reflecting the most fundamental operational shift introduced by EDC systems.

Reference (CCDM-Verified Sources):

SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Electronic Data Capture (EDC) Systems, Section 4.1 – Role of the Data Manager in EDC

ICH E6 (R2) GCP, Section 5.5.3 – Electronic Data Entry and Responsibilities

FDA 21 CFR Part 11 – Electronic Records and Signatures: Data Entry Responsibilities